| Literature DB >> 30135506 |
Lei Li1, Haiqing Wang2, Jian Yang1, Li Jiang1, Jiayin Yang3, Hong Wu1, Tianfu Wen1, Lvnan Yan1.
Abstract
Geriatric nutritional risk index (GNRI) is a novel and useful screening tool for evaluating nutritional status in elderly in-patients. We aimed to investigate whether the preoperative GNRI could be a predictive factor for outcomes in patients over 65 years of age with a diagnosis of hepatocellular carcinoma (HCC). We retrospectively enrolled 261 consecutive HCC patients after hepatectomy and classified them into four risk groups based on the GNRI values: high risk (GNRI, <82), moderate risk (GNRI, 82-92), low risk (GNRI, 92-98), and normal (GNRI, >98). We found that the lower GNRI value was significantly associated with severe postoperative complications (P < 0.001) and liver failure (P < 0.001). By multivariate logistic regression analysis, high risk- and moderate risk GNRI groups were identified as independent risk factors for postoperative serve complications and liver failure. Multivariate Cox regression analysis revealed preoperative GNRI (P < 0.001) adversely affected overall survival. In conclusion, preoperative GNRI could predict severe postoperative complications included liver failure, and the lower GNRI value was associated with worse overall survival after hepatectomy in elderly HCC patients.Entities:
Mesh:
Year: 2018 PMID: 30135506 PMCID: PMC6105611 DOI: 10.1038/s41598-018-30906-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The characteristics and clinical parameters in the four groups based on the GNRI values.
| Variables | Total | High risk | Moderate risk | Low risk | Normal Level |
|
|---|---|---|---|---|---|---|
| GNRI < 82 | GNRI 82–92 | GNRI 92–98 | GNRI > 98 | |||
| Patients (n,%) | 261, 100% | 9, 3.4% | 17, 6.5% | 38, 14.6% | 197, 75.5% | |
| Age, median (IQR) | 68 (67–70) | 69 (68–72) | 70 (66–72.5) | 68 (66–70.1) | 68 (67–70) | 0.330 |
| Preoperative TBIL (umol/L), median (IQR) | 14.1 (10.8–18.7) | 16.2 (12.5–27.1) | 17.0 (10.9–19.3) | 15.4 (10.9–19.6) | 13.3 (10.8–18.4) | 0.415 |
| Preoperative ALB (g/L), median (IQR) | 41.4 (38.1–43.8) | 28.1 (24.5–30.1)# | 34.7 (31.0–36.3) | 37.5 (35.9–38.8) | 42.7 (40.2–44.6) | <0.001 |
| Preoperative platelet (109/L), median (IQR) | 132 (91–182) | 133 (86.5–234.5) | 145 (123–173) | 105 (75.0–160.3) | 138 (91–185) | 0.280 |
| Total diameter of tumor (cm), mean (SD) | 4.9 ± 2.2 | 4.7 ± 2.2* | 5.8 ± 2.2 | 5.8 ± 2.6 | 5.3 ± 1.8 | 0.009 |
| Tumor number (single/multiple), median (IQR) | 186/75 | 3/6 | 6/11 | 8/30 | 58/139 | 0.661 |
| Preoperative AFP > 400 ng/mL (Y/N) | 184/77 | 4/5 | 6/11 | 14/24 | 53/144 | 0.413 |
| Positive HBV-DNA load (Y/N) | 70/191 | 4/5 | 5/12 | 12/26 | 49/148 | 0.512 |
| Preoperative GNRI, median (IQR) | 103.4 (98.1–109.7) | 78.4 (76.9–80.0)# | 88.7 (86.3–90.5) | 94.9 (93.5–96.9) | 106.2 (103.4–112.4) | <0.001 |
| Ishak score, median (IQR) | 6 (5–6) | 6 (5–6) | 6 (5–6) | 6 (5–6) | 6 (4–6) | 0.520 |
| Presence of MVI (Y/N) | 29/232 | 0/9 | 2/15 | 6/32 | 21/176 | 0.569 |
| Differentiation | 0.274 | |||||
| Well (n,%) | 28, 10.7% | 1,0.3% | 1,0.3% | 4,1.5% | 22,8.4% | |
| Moderate (n,%) | 218, 83.5% | 7,2.7% | 13,4.9% | 34,13.0% | 164,62.8% | |
| Poor (n,%) | 15, 5.7% | 1,0.3% | 3,1.1% | 0,0% | 11,4.2% | |
| Transfusion (Y/N) | 42/219 | 3/6 | 2/15 | 8/30 | 29/168 | 0.364 |
| Severe complication (Y/N) | 19/261 | 5/9#* | 4/17 | 0/38 | 10/197 | <0.001 |
| Liver failure (Y/N) | 41/261 | 6/9#* | 9/17 | 6/38 | 20/197 | <0.001 |
| Postoperative hospital stay (day), median (IQR) | 9 (8–11) | 10 (8–16) | 12 (8–16) | 9 (8–10) | 9 (7–11) | 0.090 |
GNRI = Geriatric Nutritional Risk Index, AFP = alpha-fetoprotein, TBIL = total bilirubin, ALB = serum albumin, PLT = platelet, MVI = micro-vascular invasion, IQR interquartile range, SD standard deviation.
#P < 0.05, when High risk group vs. Normal level-, Moderate risk- or Low risk-group.
*P < 0.05, when High risk group vs. Moderate risk- or Low risk-group.
Figure 1Incidence of liver failure (A) and severe complications (B) after hepatectomy according to GNRI. Mean GNRI was 96.29 ± 1.94 in patients who occurred postoperative liver failure (n = 41), mean GNRI was 105.3 ± 0.61 in whose without (n = 220), the significant differences between the two groups. (B) Mean GNRI was 95.76 ± 3.61 in patients (n = 19) who occurred postoperative complication, mean GNRI was 104.6 ± 0.6 in whose without (n = 242), the significant differences between the two groups.
Univariate and multivariate analyses of prognostic factors for postoperative liver failure in elderly patients with HCC.
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | HR | 95%CI | |||
| Age (year) | 1.001 | 0.892–1.122 | 0.992 | |||
| Child-Pugh score | 1.858 | 0.904–3.819 | 0.092 | |||
| Preoperative TBIL (umol/L) | 0.999 | 0.990–1.008 | 0.827 | |||
| Preoperative ALT (IU/L) | 0.997 | 0.986–1.007 | 0.520 | |||
| Preoperative AST (IU/L) | 1.007 | 0.997–1.017 | 0.193 | |||
| Preoperative ALB (g/L) | 0.979 | 0.880–1.089 | 0.695 | |||
| Preoperative platelet (109/L) | 1.004 | 0.998–1.010 | 0.189 | |||
| Preoperative AFP > 400 ng/mL (Y/N) | 1.317 | 0.572–3.030 | 0.517 | |||
| Positive HBV-DNA load (Y/N) | 1.380 | 0.541–3.517 | 0.500 | |||
| Preoperative GNRI | 0.918 | 0.865–0.975 | 0.005 | 0.910 | 0.876–0.945 | <0.001 |
|
| ||||||
| Normal Level (GNRI > 98) | 1(Reference) | 1(Reference) | ||||
| Low risk (GNRI 92–98) | 1.547 | 0.476–5.035 | 0.468 | |||
| Moderate risk (GNRI 82–92) | 9.164 | 2.141–39.233 | 0.003 | 9.956 | 3.454–28.699 | <0.001 |
| High risk (GNRI < 82) | 11.07 | 1.289–95.083 | 0.028 | 17.700 | 4.106–76.291 | <0.001 |
| Total diameter of tumor (cm) | 0.894 | 0.737–1.085 | 0.256 | |||
| Tumor number (single/multiple) | 0.486 | 0.186–1.268 | 0.140 | |||
| Transfusion (Y/N) | 0.538 | 0.197–1.467 | 0.226 | |||
GNRI = Geriatric Nutritional Risk Index, AFP = alpha-fetoprotein,TBIL = total bilirubin. AST = aspartate aminotransferase, ALT = alanine aminotransferase, ALB = serum albumin. PLT = platelet.
Univariate and multivariate analyses of prognostic factors for postoperative severe complications in elderly patients with HCC.
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | HR | 95%CI | |||
| Age (year) | 1.119 | 0.822–1.523 | 0.474 | |||
| Child-Pugh score | 2.532 | 0.970–6.611 | 0.058 | |||
| Preoperative TBIL (umol/L) | 1.000 | 0.981–1.018 | 0.967 | |||
| Preoperative ALT (IU/L) | 1.004 | 0.990–1.019 | 0.573 | |||
| Preoperative AST (IU/L) | 0.998 | 0.985–1.012 | 0.822 | |||
| Preoperative ALB (g/L) | 0.957 | 0.817–1.122 | 0.591 | |||
| Preoperative platelet (109/L) | 0.996 | 0.986–1.006 | 0.431 | |||
| Preoperative AFP > 400 ng/mL (Y/N) | 2.993 | 0.904–9.911 | 0.073 | |||
| Positive HBV-DNA load (Y/N) | 4.040 | 0.839–1.464 | 0.082 | |||
| Preoperative GNRI | 0.919 | 0.849–0.994 | 0.036 | |||
| Preoperative GNRI grade | ||||||
| Normal Level (GNRI > 98) | 1(Reference) | 1(Reference) | ||||
| Low risk (GNRI 92–98) | 0.000 | 0.000 | 0.998 | |||
| Moderate risk (GNRI 82–92) | 5.754 | 1.586–20.874 | 0.008 | 8.726 | 2.130–35.752 | 0.003 |
| High risk (GNRI < 82) | 23.375 | 5.425–100.712 | <0.001 | 26.336 | 5.576–124.383 | <0.001 |
| Ishak score | 1.000 | 0.516–1.938 | 0.999 | |||
| Total diameter of tumor (cm) | 1.105 | 0682–1.792 | 0.684 | |||
| Tumor number (single/multiple) | 0.192 | 0.050–0.745 | 0.017 | |||
| Transfusion (Y/N) | 0.180 | 0.045–0.718 | 0.015 | 0.161 | 0.046–0.560 | 0.004 |
GNRI = Geriatric Nutritional Risk Index, AFP = alpha-fetoprotein,TBIL = total bilirubin.
AST = aspartate aminotransferase, ALT = alanine aminotransferase, ALB = serum albumin.
PLT = platelet.
Figure 2Kaplan-Meier curve analysis of Overall survival (A) and Recurrence-free survival (B) in four groups based on GNRI values.
Univariate and multivariate analyses of prognostic factors for overall survival in elderly patients with HCC.
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | HR | 95%CI | |||
| Age (<70/ ≥ 70) | 1.145 | 0.831–1.578 | 0.408 | |||
| Milan Criteria (within/exceed) | 0.700 | 0.500–0.981 | 0.039 | |||
| Total diameter of tumor (cm) | 1.037 | 0.922–1.167 | 0.541 | |||
| Child-Pugh score | 1.095 | 0.874–1.372 | 0.430 | |||
| Preoperative platelet (109/L) | 1.003 | 1.001–1.005 | 0.003 | 1.003 | 1.001–1.005 | 0.001 |
| Preoperative AFP > 400 ng/mL (Y/N) | 0.762 | 0.540–1.077 | 0.124 | |||
| Positive HBV-DNA load (Y/N) | 0.958 | 0.690–1.331 | 0.799 | |||
| Preoperative GNRI | 0.981 | 0.963–0.999 | 0.039 | 0.977 | 0.964–0.990 | < 0.001 |
| Preoperative GNRI grade | ||||||
| Normal Level (GNRI > 98) | 1(Reference) | |||||
| Low risk (GNRI 92–98) | 1.265 | 0.881–1.816 | 0.202 | |||
| Moderate risk (GNRI 82–92) | 2.003 | 1.208–3.322 | 0.007 | |||
| High risk (GNRI < 82) | 1.313 | 0.669–2.577 | 0.428 | |||
| Ishak score | 1.074 | 0.907–1.273 | 0.408 | |||
| Tumor number (single/multiple) | 1.457 | 1.030–2.062 | 0.034 | |||
| Presence of MVI (Y/N) | 0.623 | 0.398–0.976 | 0.039 | 0.634 | 0.414–0.971 | 0.036 |
| Differentiation | 1.501 | 0.731–3.081 | 0.269 | |||
| Well | 1(Reference) | |||||
| Moderate | 0.703 | 0.461–1.071 | 0.101 | |||
| Poor | 0.679 | 0.341–1.353 | 0.271 | |||
| Transfusion (Y/N) | 0.903 | 0.601–1.356 | 0.623 | |||
GNRI = Geriatric Nutritional Risk Index, AFP = alpha-fetoprotein, TBIL = total bilirubin.
AST = aspartate aminotransferase, ALT = alanine aminotransferase, ALB = serum albumin.
PLT = platelet, MVI = micro-vascular invasion.